# A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

> **NCT05363215** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 32 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** S-217622

## Key facts

- **NCT ID:** NCT05363215
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-10
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-04-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05363215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05363215, "A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05363215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*